Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Short-term Investments (2020 - 2025)

Historic Short-term Investments for Strata Critical Medical (SRTA) over the last 6 years, with Q3 2025 value amounting to $53.2 million.

  • Strata Critical Medical's Short-term Investments fell 5429.03% to $53.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.2 million, marking a year-over-year decrease of 5429.03%. This contributed to the annual value of $108.8 million for FY2024, which is 2134.11% down from last year.
  • According to the latest figures from Q3 2025, Strata Critical Medical's Short-term Investments is $53.2 million, which was down 5429.03% from $54.7 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Short-term Investments registered a high of $303.2 million during Q2 2021, and its lowest value of $53.2 million during Q3 2025.
  • For the 5-year period, Strata Critical Medical's Short-term Investments averaged around $150.4 million, with its median value being $133.8 million (2023).
  • Per our database at Business Quant, Strata Critical Medical's Short-term Investments skyrocketed by 26124741.38% in 2021 and then crashed by 7703.97% in 2022.
  • Strata Critical Medical's Short-term Investments (Quarter) stood at $279.4 million in 2021, then tumbled by 46.04% to $150.7 million in 2022, then dropped by 8.28% to $138.3 million in 2023, then dropped by 21.34% to $108.8 million in 2024, then plummeted by 51.12% to $53.2 million in 2025.
  • Its last three reported values are $53.2 million in Q3 2025, $54.7 million for Q2 2025, and $85.2 million during Q1 2025.